Is l-carnitine improvement of cardiac function associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts?
Our findings indicate that acute L-carnitine treatment is of benefit to cardiac function in this model of secondary carnitine deficiency by increasing overall glucose utilization rather than normalizing fatty acid metabolism.
SIPNs show temperature-sensitive drug release following NIR laser irradiation, which can inhibit the growth and metastasis of breast cancer cells in vitro.